Skip to main content

Welcome to the Circle Health Group website. We've changed our name from BMI Healthcare. Just as before, we have thousands of specialists offering expert healthcare. Click here to find a specialist or a hospital near you.

Dr Girija Sadalage

Consultant Neurologist

MBBS, MRCP (UK), MRCP (Neurology)

Practices at: Circle Rehabilitation Birmingham, The Priory Hospital

A photo of Dr Girija Sadalage

Personal Profile

Dr Girija Sadalage is a Consultant Neurologist at Circle Rehabilitation, Birmingham. Dr Sadalage has a sub-specialist interest in Neuro-Immunology and has completed three years research on Myasthenia Gravis. She also has experience in dealing with a wide range of neurological problems, both acute and chronic.

Dr Sadalage completed her medical training at the University of Mysore in India and her Neurology training in the West Midlands. She has a PhD qualification from Nottingham University in Clinical neurology.

In 2018 Dr Sadalage was appointed as a Consultant Neurologist and works across sites at the University Hospitals Birmingham NHS Trust. She runs specialist clinics in neuroimmunology and Neuromuscular disorders, and several general clinics which incorporates a wide range of specialities such as:

  • Epilepsy
  • Headache
  • Parkinson’s disease
  • Inflammatory nervous system disorders


  • Year of medical qualification: 2000
  • Year completed Neurology Training: 2017
  • Year obtained PhD in Neurology. 
  • MBBS, MRCP (Neurology), PhD

Clinical Interests

  • Myasthenia Gravis
  • Autoimmune encephalitis
  • Neuroimmunology
  • Neuromuscular disorders

Dr Sadalage has an ongoing interest in Myasthenia Gravis and runs Myasthenia trials at the Queen Elizabeth Hospital Birmingham as a sub-PI. She also has several publications to her name.

Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis.

Sabre L, Maddison P, Sadalage G, Ambrose PA, Punga AR.J Neuroimmunol. 2018 Aug 15;321:164-170. doi: 10.1016/j.jneuroim.2018.05.003. Epub 2018 May 8.PMID: 29804819 

 miR-30e-5p as predictor of generalization in ocular myasthenia gravis.

Sabre L, Maddison P, Wong SH, Sadalage G, Ambrose PA, Plant GT, Punga AR.Ann Clin Transl Neurol. 2019 Jan 24;6(2):243-251. doi: 10.1002/acn3.692. eCollection 2019 Feb.PMID: 30847357

False-positive acetylcholine receptor antibody results in patients without myasthenia gravis.

Maddison P, Sadalage G, Ambrose PA, Jacob S, Vincent A.J Neuroimmunol. 2019 Jul 15;332:69-72. doi: 10.1016/j.jneuroim.2019.04.001. Epub 2019 Apr 3.PMID: 30959340

A Prospective Study of the Incidence of Myasthenia Gravis in the East Midlands of England.

Maddison P, Ambrose PA, Sadalage G, Vincent A.Neuroepidemiology. 2019;53(1-2):93-99. doi: 10.1159/000500268. Epub 2019 May 8.PMID: 31067543

Ocular presentation of myasthenia gravis: A natural history cohort.

Kamarajah SK, Sadalage G, Palmer J, Carley H, Maddison P, Sivaguru A.Muscle Nerve. 2018 Apr;57(4):622-627. doi: 10.1002/mus.25971. Epub 2017 Oct 6.PMID: 28881457

  • Association of British Neurologists
  • British Medical Association
  • Member of the Royal College of Physicians